ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,672Medicare Part D Prescriptions Filled, Including Refills

Rank: 231 out of 1942

$326K Total Retail Price of All Prescriptions

Rank: 405 out of 1942

597 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 597 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 597 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 7,418 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
FUROSEMIDE 363 362 1 5
LEVOTHYROXINE SODIUM 280 279 2 3
OMEPRAZOLE 280 266 2 4
LISINOPRIL 263 261 4 2
SIMVASTATIN 244 235 5 1
CITALOPRAM HBR 223 214 6 15
JANTOVEN 219 213 7 33
GABAPENTIN 167 165 8 16
POLYETHYLENE GLYCOL 3350 162 160 9 28
POTASSIUM CHLORIDE 159 158 10 17
WARFARIN SODIUM 139 138 11 11
METOPROLOL TARTRATE 123 115 12 9
TRAMADOL HCL 114 111 13 19
TAMIFLU 111 108 14 160
TRAZODONE HCL 111 111 14 24
HYDROCODONE-ACETAMINOPHEN 104 104 S3 16 12
METOPROLOL SUCCINATE 97 97 17 13
AMLODIPINE BESYLATE 93 83 18 6
DONEPEZIL HCL 87 87 19 30
RISPERIDONE 86 86 20 68
MIRTAZAPINE 84 84 21 38
SERTRALINE HCL 83 79 22 20
DIGOXIN 82 82 23 40
TAMSULOSIN HCL 81 81 24 29
VENLAFAXINE HCL ER 81 81 24 70
ISOSORBIDE MONONITRATE ER 80 79 26 42
LANTUS 76 76 27 49
NAMENDA 76 76 27 51
METFORMIN HCL 73 65 29 10
LIDODERM 73 73 29 98
NOVOLOG 70 70 31 103
ATENOLOL 65 65 32 7
LOSARTAN POTASSIUM 64 64 33 18
CYMBALTA 55 55 34 62
SPIRIVA 51 51 35 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.